CVE Intelligence
Skip to main content
HIGH

CVE-2025-2230

CVE-2025-2230 — Philips Intellispace Cardiovascular (ISCV) Improper Authentication

A flaw exists in the Windows login flow where an AuthContext token can be exploited for replay attacks and authentication bypass.

Published Updated Sources: cvelistV5, icscert

Triage

Is it exploited, how likely is exploitation, what does it touch, and how severe do the scoring sources call it.

Exploitation

Unreported

no source claims exploitation

EPSS

0%

chance of exploitation in 30 days

Affects

philips

intellispace_cardiovascular_iscv

CVSS base

7.7

HIGH

CISA SSVC assessment

Three decision points CISA publishes for the CVEs it assesses · SSVC 2.0.3. A stakeholder decision, not a severity score.

CISA

Exploitation

None

none · proof-of-concept · active

Automatable

No

can an attacker script all four kill-chain steps

Technical impact

Total

partial · total control of the vulnerable component

Affected scope

The catalog records vendors and products as separate lists, not pairs, so which product belongs to which vendor is not something this page can say.

Vendors (1)

Products (1)

intellispace cardiovascular iscv

Every base score collected

Sources score independently and disagree; each row says who scored it and under which version.

ScoreVersionSeverityExpl.ImpactSource
7.7CVSS 3.1HIGHcvelistV5

Weakness & attack patterns

  • CWE-287

Attack patterns reported against this CVE. The ATT&CK techniques below are inferred from its weakness class.

  • T1548Abuse Elevation Control Mechanism
  • T1040Network Sniffing
  • T1185Browser Session Hijacking

References

2 on the record

Elsewhere on this site

  • philipsevery CVE for this vendor
  • CWE-287other pages naming this weakness

Not in any source we poll

Listed rather than left blank: an empty field and an unmeasured one look identical on screen, and only one is a reason to look elsewhere.

  • No confirmed IOCs, IP addresses, domains, file hashes, or malware artifacts supplied.
  • No organization-specific asset inventory, compensating-control status, or patch deployment evidence supplied.
  • No exploit packet captures, log samples, or incident case IDs supplied.